Spirometers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Spirometers Market Analysis

The Spirometers Market size is estimated at USD 602.70 million in 2024, and is expected to reach USD 803.89 million by 2029, growing at a CAGR of 5.93% during the forecast period (2024-2029).

COVID-19 impacted the growth of the spirometer market owing to the decline in the diagnosis and treatment of patients suffering from respiratory diseases. For instance, according to the research study published in Elsevier Public Health Emergency, September 2021, it has been observed that the use of spirometry is restricted to immunocompromised patients for urgent treatment only, such as bone marrow transplants, lung transplants, and pre-chemotherapy treatments. Also, according to the research study published in PLOS One in February 2021, it has been observed that the risk for all-cause mortality is approximately two times higher in patients with COPD than in those without COPD, and a steep decline in visits to hospitals and clinics due to the lockdown measures imposed by the government has severely impacted the market growth during a pandemic. However, resumed diagnosis and treatment services for respiratory diseases and increased patient visits have increased market growth, are expected to regain their potential over the years, and may record healthy growth during the forecast period.

Factors such as the rise in the prevalence of chronic obstructive pulmonary disease (COPD), technological advancements in the field of spirometers, and a growing preference for home healthcare are boosting market growth.

The rising burden of COPD among the population raises the need for early detection of the COPD condition, which is expected to fuel the demand for spirometry tests. This is anticipated to augment market growth over the forecast period. For instance, as per an article published in the European Respiratory Journal, in November 2021, about 49,453,852 Europeans are expected to suffer from COPD by 2050, as compared to 36,580,965 in 2020. In addition, as per the same source, the Netherlands is expected to have the highest prevalence of COPD (14.6%) in Europe by 2050.

Additionally, according to the study published in PLOS ONE in January 2021, in France, there are currently 2.6 million people who have chronic obstructive pulmonary disease (COPD), and by 2025, that number is expected to rise to 2.8 million. Also, as per the 2022 statistics published by the NHS, about 1.17 million people in England were diagnosed with chronic obstructive pulmonary disorder (COPD) in 2020-2021, accounting for 1.9% of the total population. Thus, the expected increase in the number of people suffering from COPD is expected to increase the demand for technologically advanced spirometers, hence propelling market growth.

Furthermore, technological advances and the increasing portability and ease of operation of devices are anticipated to drive segment growth. For instance, in March 2021, Vyaire Medical launched the AioCare (HealthUp SA, Poland) mobile spirometry system in more than 15 countries, including Australia and other countries. This clinically proven technology expands upon Vyaire's deep respiratory diagnostics expertise and allows physicians to promptly diagnose pulmonary diseases including asthma and COPD as accurately as hospital-grade spirometers.

Moreover, the preference for home healthcare has increased among patients, which has increased the development of tele-spirometers or virtual spirometry tests, which is also contributing to the market's growth. For instance, in June 2021, eResearch Technology (ERT) launched ERT iSpiro Virtual Visits, which enables real-time coaching during at-home pulmonary function tests (PFT). iSpiro Virtual Visits makes it possible to gather high-quality spirometry data at home, keeping respiratory clinical studies on schedule, even when a patient is unable to visit a clinic.

Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. But not enough people know about chronic obstructive pulmonary disease (COPD), which is likely to slow the growth of the spirometer market over the next few years.

Spirometers Market Trends

This section covers the major market trends shaping the Spirometers Market according to our research experts:

Hand-Held is Expected to Witness Significant Growth in the Spirometers Market

Spirometers Industry Segmentation

As per the scope of the report, a spirometer is a medical device that is used to measure the proper functioning of the lungs, where the volume of air inhaled and exhaled from the lungs is measured after maximum inhalation by the patient. A spirometer helps in the identification of different respiratory diseases, such as bronchitis, chronic lung diseases that are obstructive, emphysema, asthma, and other breathing diseases, for screening in an occupational environment. A spirometer is used to analyze lung function before surgery and predict respiratory diseases. The spirometers market is segmented by type (hand-held and table-top), technology (volume measurement and flow measurement), application (asthma, COPD, cystic fibrosis, and others), end-user (hospitals and clinics and home healthcare), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.